The role of gut microbiota in health and diseases
Article Sidebar
-
human, microbiota, gastrointestinal tract, dysbiosis, health and disease
Abstract
ABSTRACT
ABSTRACT
Microbiota contributes a crucial part in the human hosts' health and actively provides to the emergence of various diseases. The optimal composition of healthy intestinal microbiota varies from person to person. The more various and abundant of the microbiota, the greater their resistance to outside hazards. Colonization of the microbiota in the human body starts after delivery and develops continuously from infant to adult. The largest microbial colony is constructed in the lower part of the adult human digestive tract. The composition of the human intestinal microbiota alters promptly during the beginning of life and is steady. It has been described the close relationship among dysbiosis of the intestinal microbiota with intestinal and non-intestinal diseases. Nevertheless, it is uncertain whether dysbiosis is the culprit of the disease or only as a result of the disease. Human microbiota's role must be investigated more deeply so that later it can be developed for the prevention, diagnosis of disease, and more effective treatment strategies in the future. In this minireview, we will describe the development of the gut microbiota, its interaction with our bodily systems and defense, the multiple causes of dysbiosis, and its impact on several metabolic in inflammatory diseases in humans. With this insight, it is hoped that we can be more cautious about using antibiotics, avoid things that lead to dysbiosis, and handle diseases more holistically, putting the balance of the microbiota into account.
Â
Keywords: Â human, microbiota, gastrointestinal tract, dysbiosis, health and disease
Corresponding author: deasyfetarayani@gmail.com
Full text article
References
Azad, M. A. K., Sarker, M., Li, T., & Yin, J (2018). Probiotic species in the modulation of gut microbiota: an overview. BioMed Research International, 2018:9478630. doi: 10.1155/2018/9478630.
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M. & Lauren J. Owen, L. J (2015). Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease, 26: 10.3402/mehd.v26.26191. doi: 10.3402/mehd.v26.26191
Eppinga, H., Fuhler, G. M., Peppelenbosch, M. P., & Hecht, G. A (2016). Gut microbiota developments with emphasis on inflammatory bowel disease: report from the Gut Microbiota for Health World Summit 2016. Gastroenterology, 151(2):e1–e4. doi: 10.1053/j.gastro.2016.06.024.
Feng, X. W., Ding, W. P., Xiong, L. Y., Guo, L., Sun, J. M. & Xiao, P (2018). Recent advancements in intestinal microbiota analyses: a review for non-microbiologists. Current Medical Science, 38(6): 949-961. doi: 10.1007/s11596-018-1969-z.
Iebba, V., Totino, V., Gagliardi, A., Santangelo, F., Cacciotti, F., Trancassini, M., Mancini, C., Cicero, C., Pantanella, F & Schippa, S (2016). Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiologica, 39(1): 1-12. PMID: 26922981
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E (2017). Dysbiosis and the immune system. Nature Reviews Immunology,17(4):219-232. doi: 10.1038/nri.2017.7.
McBurney, M. I., Davis, C., Fraser, C. M., Schneeman, B. O., Huttenhower, C., Verbeke, K., Walter, J., & Latulippe, M. E (2019). Establishing what constitutes a healthy human gut microbiome: state of the science, regulatory considerations, and future directions. Journal of Nutrition, 149(11):1882-1895. doi:10.1093/jn/nxz154
Oliphant, K., & Allen-Vercoe, E. (2019). Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome, 7(1): 1-15. doi:10.1186/s40168-019-0704-8
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms, 7(1):14. doi: 10.3390/microorganisms7010014
Round, J. L., & Mazmanian, S. K (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology, 9(5): 313-323. doi:10.1038/nri2515
Schippa, S., & Conte, M. P (2014). Dysbiotic events in gut microbiota: impact on human health. Nutrients, 6(12): 5786-5805. doi:10.3390/nu6125786
Scott, K. P., Antoine, J.-M., Midtvedt, T., & van Hemert, S (2015). Manipulating the gut microbiota to maintain health and treat disease. Microbial Ecology in Health & Disease, 26:25877. doi:10.3402/mehd.v26.25877
Shreiner, A. B., Kao, J. Y., & Young, V. B (2015). The gut microbiome in health and in disease. Current Opinion in Gastroenterology, 31(1): 69-75. doi:10.1097/MOG.0000000000000139
Shi, Y., Dong, Y., Huang, W., Zhu, D., Mao, H., & Su, P. (2016). Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis. PLoS ONE, 11(6):1-18. doi:10.1371/journal.pone.0157259
Sovner, R. (1989). The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. Journal of Clinical Psychiatry, 50(3 Suppl.), 40-43. PMID: 2494159
Su, X., Xue, Y., Wei, J., Huo, X., Gong, Y., Zhang, H., Han, R., Chen, Y., Chen, H. & Chen, J (2018). Establishment and characterization of gc-006-03, a novel human signet ring cell gastric cancer cell line derived from metastatic ascites. Journal of Cancer, 9(18): 3236-3246. doi:10.7150/jca.26051
Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C. & Meschi, T (2019). Gut microbiota, muscle mass and function in aging: a focus on physical frailty and sarcopenia. Nutrients, 11(7): 1-21. doi:10.3390/nu11071633.
Toor, D., Wasson, M. K., Kumar, P., Karthikeyan, G., Kaushik, N. K., Goel, C., Singh, S., Kumar, A. & Prakash, H (2019). Dysbiosis disrupts gut immune homeostasis and promotes gastric diseases. International Journal of Molecular Sciences, 20(10):1-14. doi:10.3390/ijms20102432
Wang, B., Yao, M., Lv, L., Ling, Z. & Li, L (2017). The human microbiota in health and disease. Engineering, 3(1): 71-82. doi:10.1016/J.ENG.2017.01.008
Weiss, G. A. & Hennet, T (2017). Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences, 74(16):2959-2977. doi:10.1007/s00018-017-2509-x
Zhang, W., Li, J., Lu, S., Han, N., Miao, J., Zhang, T., Qiang, Y., Kong, Y., Wang, H., Gao, T., Liu, Y., Li, X., Peng, X., Chen, X., Zhao, X., Che, J., Zhang, L., Chen, X., Zhang, Q., Hu, M., Li, Q & Kan, B (2019). Gut microbiota community characteristics and disease-related microorganism pattern in a population of healthy Chinese people. Scientific Reports, 9(1), 1–10. doi:10.1038/s41598-018-36318-y
Authors
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.